A disposable insulin pen is used to infuse insulin as a part of the treatment for diabetes. Insulin is a hormone produced by the pancreas which is reduced due to diabetes which is a metabolic disease. Disposable insulin pens come prefilled with insulin and are discarded once they get empty. Majority of the disposable insulin pens used in the United States carry 300 units of insulin and are generally sold in boxes of five. These types are more travel-friendly and convenient as compared to other reusable pens, and this is because one need not reload any cartridges. However, disposable pens are not as cost-efficient as reusable pens and cartridges. There are various brands and model available currently in the market. An insulin-dependent patient needs to keep various factors in mind before selecting the best-suited disposable insulin pen. For instance, the brands and types of insulin available for a particular pen, the total number of insulin units the pen can hold when full, the maximum amount that can be injected with the disposable pen, the amount of strength and adroitness needed to function the pen, ways to rectify the mistake in case of wrong dose in the pen, and many more.
Top Manufactures Analysis of Disposable Insulin Pen: BD, Levemir, Novo Nordisk, Sanofi-aventis
To Browse Complete Report, Click Here: http://www.qyresearchgroups.com/report/global-disposable-insulin-pen-market-research-report-2016
The global disposable insulin pen market is anticipated to garner a substantial amount of revenue share while growing at a lucrative CAGR during the forecast period. The factors contributing towards the market’s growth are increased prevalence of diabetes across the globe, especially amongst the geriatric population, enhanced technology in relation to insulin delivery, and preciseness with the device and awareness pertaining to diabetes care. With global modernization in technology and e-healthcare, various services include healthcare apps on smart devices which assist patients with timely dose reminders and alerts is predicted to propel the growth of this industry in the future. One more factor driving this market during the forecast period is the fact that the disposable insulin pens are more convenient to carry around and user-friendly as compared to the reusable ones. However, disposable pens are not very cost effective and not everyone can afford them; this might withheld the growth of this market on a global level.
To Request Sample Copy of This Report: http://www.qyresearchgroups.com/request-sample/154028
Furthermore, there has been an increase in the healthcare infrastructure for diabetes patients, a wireless technology which transmits data to a said mobile application, lucrative results of the devices, etc., will boost this market further. Some of the major manufacturing market players of the global disposable insulin pens are Levemir, Novo Nordisk, Sanofi-aventis, F. Hoffman-La Roche AG, Eli Lilly and Company, Medtronic, Lantus Solostar, Becton Dickson and Company, Humulin Pen, and HumaPen LUXURA HD.
QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world’s most complete and current database of expert insights on global industries, companies, products, and trends.
Room B1510, ShijiKemao Building, No.66, Zhongguancun East Road,
Haidian District, Beijing, 100190, China